HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning.

Abstract
The increasing threat of nerve agent use for terrorist purposes against civilian and military population calls for effective therapeutic preparedness. At present, administration of atropine and an oxime are recommended, although effectiveness of this treatment is not proved in clinical trials. Here, monitoring of intoxications with organophosphorus (OP) pesticides may be of help, as their actions are closely related to those of nerve agents and intoxication and therapy follow the same principles. To this end, the clinical course of poisoning and the effectiveness of antidotal therapy were investigated in patients requiring artificial ventilation being treated with atropine and obidoxime. However, poisoning with OP pesticides shows extremely heterogeneous pictures of cholinergic crisis frequently associated with clinical complications. To achieve valuable information for the therapy of nerve agent poisoning, cases resembling situations in nerve agent poisoning had to be extracted: (a) intoxication with OPs forming reactivatable OP-AChE-complexes with short persistence of the OP in the body resembling inhalational sarin intoxication; (b) intoxication with OPs resulting rapidly in an aged OP-AChE-complex resembling inhalational soman intoxication; (c) intoxications with OPs forming a reactivatable AChE-OP complex with prolonged persistence of the OP in the body resembling percutaneous VX intoxication. From these cases it was concluded that sufficient reactivation of nerve agent inhibited non-aged AChE should be possible, if the poison load was not too high and the effective oximes were administered early and with an appropriate duration. When RBC-AChE activity was higher than some 30%, neuromuscular transmission was relatively normal. Relatively low atropine doses (several milligrams) should be sufficient to cope with muscarinic symptoms during oxime therapy.
AuthorsH Thiermann, L Szinicz, P Eyer, N Felgenhauer, T Zilker, F Worek
JournalToxicology (Toxicology) Vol. 233 Issue 1-3 Pg. 145-54 (Apr 20 2007) ISSN: 0300-483X [Print] Ireland
PMID17161895 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Chemical Warfare Agents
  • Cholinesterase Reactivators
  • Organophosphorus Compounds
  • Pesticides
  • Cholinesterases
Topics
  • Animals
  • Chemical Warfare Agents (chemistry, pharmacokinetics, poisoning)
  • Cholinesterase Reactivators (administration & dosage, therapeutic use)
  • Cholinesterases (metabolism)
  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Structure
  • Neurotoxicity Syndromes (drug therapy, enzymology)
  • Organophosphate Poisoning
  • Organophosphorus Compounds (chemistry, pharmacokinetics)
  • Pesticides (chemistry, pharmacokinetics, poisoning)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: